Alzamend Neuro Working Capital Growth & History (ALZN)

Alzamend Neuro's working capital was $418,345 for fiscal 2026.

View full Alzamend Neuro company overview

Alzamend Neuro annual working capital history

Alzamend Neuro annual working capital

Fiscal yearPeriod endedWorking capitalChangeGrowth
20262026-04-30$418,345−$3.1M−88.19%
20252025-04-30$3.5M$6.3M
20242024-04-30−$2.8M−$5.7M
20232023-04-30$3.0M−$10.3M−77.62%
20222022-04-30$13.2M$11.2M+558.17%
20212021-04-30$2.0M$1.2M+144.97%
20202020-04-30$821,709

Alzamend Neuro working capital trends

Over the last five fiscal years, Alzamend Neuro's working capital decreased from $2.0M to $418,345, a change of −$1.6M. The latest reported quarter, Q4 2026, shows $418,345.

About the metric

What working capital means

Working capital is the difference between current assets and current liabilities. It provides a snapshot of short-term operating liquidity, although negative working capital can be normal for some business models and the measure is often not meaningful for banks.

Calculation and source

How working capital is calculated

TickerStat calculates working capital as reported current assets minus reported current liabilities at the same balance-sheet date. Missing current classifications are not assumed to be zero. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Alzamend Neuro source filings ↗

Community posts

It’s quiet here.

No posts about ALZN yet. Start the conversation.

Write the first post